[Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis

<div>Histogram and area of SUCRA in OS. The OS indicator SUCRA values ranked cetuximab, CTX, icotinib, gefitinib, afatinib, and erlotinib in descending order. This demonstrates that erlotinib has the highest chance of achieving the best OS, whereas cetuximab has the lowest.</div>

Disease Markers

fig4

Figure 4

Figure 4: [Retracted] The Use of Cytotoxic Drugs as First Line Chemotherapy for EGFR (+) Nonsquamous NSCLC: A Network Meta-Analysis 